(Q40767575)

English

A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

based on heuristic

inferred from title

hepatitis A vaccine

1 reference

based on heuristic

inferred from title

Lia Laura Lewis-Ximenez

5

object named as

Lia Laura Lewis-Ximenez

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Marcelo Alves Pinto

8

object named as

Marcelo Alves Pinto

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Juliana Gil Melgaço

1

object named as

Juliana Gil Melgaço

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

7

object named as

Oswaldo Gonçalves Cruz

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Lucas Nóbrega Morgado

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Marta Almeida Santiago

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Jaqueline Mendes de Oliveira

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Bárbara Hasselmann

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Claudia Lamarca Vitral

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

2 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

3813-3820

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

A review of the long-term protection after hepatitis A and B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Inactivated hepatitis A vaccine in childhood: implications for disease control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Antibody persistence and immune memory elicited by combined hepatitis A and B vaccination in older adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Immunogenicity of booster vaccination with a virosomal hepatitis A vaccine after primary immunization with an aluminum-adsorbed hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Successful memory response following a booster dose with a virosome-formulated hepatitis a vaccine delayed up to 11 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Excellent booster response 4 to 8 years after a single primary dose of an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: Regional analyses according to the endemic context

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Cell mediated and antibody immune response to inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Evidence of hepatitis A virus person-to-person transmission in household outbreaks.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Could oral fluid be used to evaluate anti-hepatitis A virus status in individuals living in difficult-to-access areas?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Virus-specific CD8 T cells: activation, differentiation and memory formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Antigen-specific responses assessment for the evaluation of Bordetella pertussis T cell immunity in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Flow cytometric assessment of antigen-specific proliferation in peripheral chicken T cells by CFSE dilution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Detection of cellular immunity to rabies antigens in human vaccinees

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Central memory and effector memory T cell subsets: function, generation, and maintenance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Plasmodium vivax infection induces expansion of activated naïve/memory T cells and differentiation into a central memory profile

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Development, trafficking, and function of memory T-cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

CD4+ memory T cells: functional differentiation and homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

T-cell memory differentiation: insights from transcriptional signatures and epigenetics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Shaping successful and unsuccessful CD8 T cell responses following infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Impaired function of CD4+/CD25+ T regulatory lymphocytes characterizes the self-limited hepatitis A virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Hepatitis A virus: host interactions, molecular epidemiology and evolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Impact of the single-dose immunization strategy against hepatitis A in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

A Brazilian hepatitis A virus isolated and adapted in primate and primate cell line as a chance for the development of a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.099

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2015.06.099

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40767575&oldid=2019536337"